ZTS - Zoetis gains as Q1 beat addresses concerns over arthritis drug
2024-05-02 11:40:03 ET
More on Zoetis
- Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment
- Zoetis: My Favorite Healthcare Stock Right Now
- Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness
- Zoetis Non-GAAP EPS of $1.38 beats by $0.04, revenue of $2.2B beats by $50M
- Zoetis Q1 2024 Earnings Preview